protein-ligand interactions from mol...
| |
protein-ligand interactions from molecular recognition to drug design /
|
chemogenomics in drug discovery :
| |
chemogenomics in drug discovery :
|
evolutionary algorithms in molecular...
| |
evolutionary algorithms in molecular design /
|
data mining in drug discovery
| |
data mining in drug discovery
|
pharmacokinetics and metabolism in d...
| |
pharmacokinetics and metabolism in drug design
|
thermodynamics and kinetics of drug ...
| |
thermodynamics and kinetics of drug binding
|
voltage-gated ion channels as drug t...
| |
voltage-gated ion channels as drug targets /
|
|
|
drug bioavailability :
|
animal models for human cancer :
| |
animal models for human cancer :
|
quantum medicinal chemistry /
| |
quantum medicinal chemistry /
|
reactive drug metabolites
| |
reactive drug metabolites
|
|
|
hit and lead profiling
|
prodrugs and targeted delivery
| |
prodrugs and targeted delivery
|
animal models for human cancer :
| |
animal models for human cancer :
|
bioisosteres in medicinal chemistry
| |
bioisosteres in medicinal chemistry
|
qsar : hansch analysis and related a...
| |
qsar : hansch analysis and related approaches /
|
lipophilicity in drug action and tox...
| |
lipophilicity in drug action and toxicology /edited by vladimir pliska, bernard testa, and han van de waterbeemd.
|
pharmacokinetics and metabolism in d...
| |
pharmacokinetics and metabolism in drug design /
|
g protein-coupled receptors as drug ...
| |
g protein-coupled receptors as drug targets :
|
transporters as drug targets
| |
transporters as drug targets
|